Extraoesophageal manifestations of gastro-oesophageal reflux

Gut

Volumn 54, Issue 10, 2005, Pages 1492-1499

  Poelmans, J ^b   Tack, J ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ALGORITHM; ASTHMA; CHRONIC OTITIS MEDIA; CLINICAL FEATURE; CLINICAL PRACTICE; COUGHING; DRUG MEGADOSE; EAR NOSE THROAT DISEASE; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNX DISORDER; LARYNX SPASM; PH; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; SINUSITIS;

ALGORITHMS; ASTHMA; CHRONIC DISEASE; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGEAL DISEASES; LUNG DISEASES; OTITIS MEDIA; OTORHINOLARYNGOLOGIC DISEASES; PROTON PUMPS;

EID: 25444529459     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.053025     Document Type: Review

References (74)

1. Richter JE. Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis 1997;8:75-89.
2. Wong RK, Hanson DG, Waring PJ, et al. ENT manifestations of of gastroesophageal reflux. Am J Gastroenterol 2000;95(8 suppl):S15-S22.
3. Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med 2003;115(suppl 3A):39S-44.
4. Vaezi MF. Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence. Am J Med 2003;115(suppl 3A):97S-104.
5. Malagelada JR. Review article: supra-esophageal manifestations of gastroesophageal reflux disease. Aliment Pharmacol Ther 2004;19(suppl 1):43-8.
6. Ossakow SJ, Elta G, Bogdasarian R, et al. Oesophageal reflux and dysmotility as the basis of persistent cervical symptoms. Ann Otol Rhinol Laryngol 1987;96:387-92.
7. Poelmans J, Feenstra L, Demedts I, et al. The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose and throat symptoms. Am J Gastroenterol 2004;99:1419-26.
8. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113:755-60.
9. El-Serag HB, Gilger M, Kuebeler M, et al. Extraesophageal associations of gastroesophageal reflux disease in children without neurological defects. Gastroenterology 2001;121:1294-9.
10. El-Serag HB, Hepworth EJ, Lee P, et al. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol 2001;96:2013-18.
11. Harding SM. Pulmonary complications of gastroesophageal reflux. In: Castell DO, Richter JE, eds. In: The esophagus, 4th, edn. Philadelphia: Lippincott Williams and Wilkins, 2004:530-45.
12. Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 1998;114:275-83.
13. Field SK, Gelfand GAJ, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999;116:766-74.
14. Coughlan JL, Gibson PG, Henry RL. Medical treatment for reflux oesophagitis does not consistently improve asthma control: a systematic review. Thorax 2001;56:198-204.
15. Irwin RS, Madison JM. Anatomic diagnostic protocol in evaluating chronic cough with specific reference to gastroesophageal reflux disease. Am J Med 2000;108(suppl 4A):126S-30.
16. D'Urzo A, Jugovic P. Chronic cough. Three most common causes. Can Fam Physician 2002;48:1311-16.
17. Ours TM, Kavaru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999;94:3131-8.
18. Kiljander TO, Salomaa ERM, Hietanen EK, et al. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000;16:633-8.
19. Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968;78:1941-7.
20. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313-17.
21. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of anti-reflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995;104:550-5.
22. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111:2147-51.
23. Smit CF, van Leeuwen JA, Mathus-Vliegen LM, et al. Gastropharyngeal and gastroesophageal reflux in globus and hoarseness. Arch Otolaryngol Head Neck Surg 2000;126:827-30.
24. Delahunty JE. Acid laryngitis. J Laryngol Otol 1972;86:335-42.
25. Ylitalo R, Ramel S. Extraesophageal reflux in patients with contact granuloma: a prospective controlled study. Ann Otol Rhinol Laryngol 2002;111:441-6.
26. Jindal JR, Milbrath MM, Shaker R, et al. Gastroesophageal reflux disease as a likely cause of "idiopathic" subglottic stenosis. Ann Otol Rhinol Laryngol 1994;103:186-91.
27. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001;96:979-83.
28. Eherer AJ, Habermann W, Hammer HF, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled study. Scand J Gastroenterol 2003;38:462-7.
29. Loehrl TA, Smith TL. Chronic sinusitis and gastroesophageal reflux: are they related? Curr Opin Otolaryngol Head Neck Surg 2004;12:18-20.
30. Tasker A, Dettmar PW, Panetti M, et al. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope 2002;112:1930-4.
31. Poelmans J, Tack J, Feenstra L. Chronic middle ear disease and gastroesophageal reflux disease/a causal relation? Otol Neurotol 2001;22:447-50.
32. Poelmans J, Tack J, Feenstra L. Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. Ann Otol Rhinol Laryngol 2002;111:933-8.
33. Noordzij JP, Khidr AK, Desper E, et al. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002;112:2192-5.
34. Toohill RJ, Kuhn JC. Role of refluxed acid in pathogenesis of laryngeal disorders. Am J Med 1997;103(suppl 5A):100S-6.
35. Poelmans J, Tack J, Feenstra L. The role of (duodeno)esophagopharyngeal reflux in chronic unexplained excessive throat phlegm. Dig Dis Sci 2005;50:824-32.
36. Bortolotti M. Laryngospasm and reflex central apnoea caused by aspiration of refluxed gastric content in adults. Gut 1989;30:233-8.
37. Loughlin G, Koufman JA. Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope 1996;106:1502-5.
38. Maceri RAA, Zim S. Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). Laryngoscope 2001;111:1976-9.
39. Morrison M, Rammage L, Emmani AJ. The irritable larynx syndrome. J Voice 1999;13:447-55.
40. Poelmans J, Tack J, Feenstra L. Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux. Dig Dis Sci 2004;49:1868-74.
41. Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour ambulatory pressure, pH, and impedance monitoring. Gut 2005;54:449-54.
42. Ing AJ, Ngu MC, Breslin ABX. Pathogenesis of chronic persistent cough associatea with gastroesophageal reflux. Am J Respir Crit Care Med 1994;149:160-7.
43. Kiljander TO. The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough. Am J Med 2003;115(suppl 3A):65S-71.
44. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with "reflux laryngitis." Gastroenterology, 1991;100:305-10.
45. Sataloff RT, Castell DO, Katz PO, et al. Reflux laryngitis and related disorders. San Diego: Singular Publishing Group, 1999.
46. Cool M, Poelmans J, Koek G, et al. Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol 2004;99:2317-23.
47. Champion GL, Richter JE. Atypical presentations of gastroesophageal reflux disease: chest pain, pulmonary and ear, nose, throat manifestations. Gastroenterologist 1993;1:18-33.
48. Kahrilas PJ, Ergun GA. Otolaryngologic manifestations of GERD. In: Richter JE, eds. Ambulatory esophageal pH monitoring: a practical approach and clinical applications, 2nd edn. New York: Igaku-Shoin, 1997:133-48.
49. Kamel PL, Hanson D, Kahrilas PJ. Omeprazole for the treatment of posterior laryngitis. Am J Med 1994;96:321-6.
50. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and esophageal 24-hour pH monitoring and esophageal manometry in patients with reflux disease resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4:485-95.
51. Fass R, Mackel C, Sampliner RE. 24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. J Clin Gastroenterol 1994;19:97-9.
52. Holloway RH, Dent J, Narielvala F, et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole. Gut 1996;38:649-54.
53. Katzka DA, Paoletti V, Leite L, et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;91:2110-13.
54. Bough DI, Sataloff RT, Castell DO, et al. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice 1995;9:205-11.
55. Koufman JA. The Otolaryngologic manifestations of gastroesophageal reflux disease (GERD). Laryngoscope 1991;101(suppl):1-78.
56. Koufman JA, Belafsky P, Bach K, et al. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002;112:1606-9.
57. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002;16:564-79.
58. Vaezi M, Richter J, Stasney CR, et al. A randomized, double-blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux. Gastroenterology 2004;126:A22.
59. Poe RH, Kalfay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003;123:679-84.
60. Tack J, Koek G, Demedts I, et al. Gastroesophageal reflux disease poorly responsive to proton pump inhibitors: acid reflux, bile reflux or both? Am J Gastroenterol 2004;99:981-8.
61. Levy AH, Banwait KS, DiMarino AJ, et al. Utility of twenty-four hour esophageal pH monitoring in patients with persistent symptoms on PPI therapy. Gastroenterology 2004;126:A19.
62. Vaezi MF, Charbel S. On-therapy pH monitoring: Usually recommended but should we do it? Gastroenterology 2004;126:A82.
63. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-606.
64. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour impedance and pH monitoring (24-hr Imp-pH) in the evaluation of GERD patients with persistent symptoms despite bid proton pump inhibitors (PPI): A multicenter study. Gastroenterology 2004;126:A324.
65. Poelmans J, Tack J, Sifrim D, et al. Role of bile reflux in patients with gastroesophageal reflux-related ENT symptoms. Neurogastroenterology 1999;11:A281.
66. Wiener GJ, Copper JB, Wu WC, et al. Is hoarseness an atypical manifestation of gastroesophageal reflux (GER)? An ambulatory 24-hour pH study. Gastroenterology 1986;90:A1691.
67. Ossakow SJ, Elta G, Bogdasarian R, et al. Esophageal reflux and dysmotility as the basis of persistent cervical symptoms. Ann Otol Rhinol Laryngol 1987;96:387-92.
68. Batch AJG. Globus pharyngeus (part 1). J Laryngol Otol 1988;102:152-8.
69. McNally PR, Maydonovic CL, Prosek RA, et al. Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness. Dig Dis Sci 1989;34:1900-4.
70. Ness J, Sontag S, Schnell T. Prevalence of gastroesophageal reflux (GER) in consecutive patients with hoarseness. Gastroenterology 1992;102:A134.
71. Tauber S, Gross M, Issing WJ. Association of laryngopharyngeal symptoms with gastroesophageal reflux disease. Laryngoscope 2002;112:879-86.
72. Koufman JA, Belarsky P, Bach K, et al. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002;112:1606-9.
73. Poelmans J, Feenstra L, Tack J, et al. Determinants of long-term outcome of patients with reflux-related ENT symptoms. Dig Dis Sci 2005 (in press).
74. Johnson DA, Benjamin SB, Vakil NB, et al. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophaqeal reflux disease symptoms: a randomised, double-blind, placebo-controlled study of efficacy and safety. Am J Gastroenterol 2001;96:27-34.